BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:20 PM
 | 
May 05, 2009
 |  BC Extra  |  Company News

Amylin submits NDA for exenatide once weekly

Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) submitted an NDA to FDA for exenatide once weekly to treat Type II diabetes. Amylin developed the...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >